Antiplatelet drug therapy has become one of the cornerstones of treatment for patients with cardiovascular disease. Large clinical trials have shown that antiplatelet medications have important ...
Background: The use of antiplatelet therapy in combination with oral anticoagulants remains controversial. The objective of this study was to estimate and compare the incidence of adverse and ...
Finally, a recent study suggested that although prasugrel significantly reduces thrombotic events in patients with ACS undergoing PCI because of its superior antiplatelet potency compared with ...
As climate change brings more intense heat waves, scientists are trying to understand how certain medications interact with ...
Among 3,400 patients who underwent PCI with DES and survived event free to 1 month on dual antiplatelet therapy (DAPT) with both ticagrelor and aspirin, the trial showed no difference in major adverse ...
What’s more, onions are in the allium family of vegetables, which means they contain antiplatelet agents that can prevent cardiovascular disease. A 2012 study found that when raw onions were heated in ...
The effectiveness of prophylactic antiplatelet agents to prevent HAT has not been studied in depth, despite the clinical importance of this postoperative complication. Vivarelli and colleagues ...
The stock has soared 110% in the last 10 years, driven by its triumphs in medical science. Valued at $235 billion by market cap, AZN stock is up 12.2% year-to-date, compared to the S&P 500’s ($SPX) ...
A recent trial found that patients with acute coronary syndrome (ACS) who have undergone percutaneous coronary intervention ...
A second antiplatelet, such as ticagrelor, is often offered in combination with aspirin for a defined period of time, generally up to 12 months. There have been many reports of people continuing on ...
Opens in a new tab or window ATLANTA -- In select patients undergoing percutaneous coronary intervention (PCI) for acute coronary syndromes who were event-free for 1 month on dual antiplatelet ...
A second antiplatelet, such as ticagrelor, is often offered in combination with aspirin for a defined period of time, generally up to 12 months. There have been many reports of people continuing on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback